Clinical Trial Update: CM082 and JS001 in Patients With Advanced Small-cell Lung Cancer (SCLC) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for CM082 and JS001 in patients with advanced small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• CM082
• JS001 (PD-1 inhibitor)

Snippet

Sponsor: AnewPharma | Conditions: Small Cell Lung Cancer | Phase 2 | Status: UNKNOWN